Representatives of regulatory authorities and industry groups from around the world have reached general agreement on a regulatory template for smoothing out minor differences in how the pharmaceutical industry manufactures drug products for different countries.
Global manufacturers have long complained about the necessity of juggling multiple variations of drug products made using various combinations of old and new manufacturing processes simply because of the time,...